AKT2 Loss Impairs BRAF-Mutant Melanoma MetastasisSiobhan K. McRee(Tufts University), Philip W. Hinds(Tufts University)bioRxiv (Cold Spring Harbor Laboratory)August 24, 202310.1101/2023.08.24.554685Cited by 2SaveCiteExport RISWatch citationsRelated PapersPhosphorylation of Ezrin by Cyclin-Dependent Kinase 5 Induces the Release of Rho GDP Dissociation Inhibitor to Inhibit Rac1 Activity in Senescent Cells|Cancer Research|2006|33AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis|Cancers|2023|7